OTC Naloxone May Get Another Push From US FDA As Agency Prepares Novel Switch Proposed Rule

 
• By Derrick Gingery
  
Narcan device
FDA Commissioner Robert Califf said the instructions for use will be important for OTC naloxone products. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from R&D

More from Pink Sheet